Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR

This article was originally published in The Tan Sheet

Executive Summary

FDA's advance notice of proposed rulemaking for OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register

You may also be interested in...



Colgate Bids To Expand U.S. Toothpaste Lineup Through FDA Rulemaking

Colgate seeks regulatory approval for a version of its Colgate Sensitive Multi-Protection toothpaste in a formulation it already markets internationally. The request made in a citizen petition comes after Colgate’s plan to expand its U.S. toothpaste business failed when FDA did not give approval for Sensitive Pro-Relief.

P&G, Pfizer Disagree On Antiplaque Claims Support, Stannous Fluoride

Procter & Gamble and Pfizer take opposing views on the way therapeutic stand-alone antiplaque claims should be regulated in comments submitted to FDA Feb. 20

P&G, Pfizer Disagree On Antiplaque Claims Support, Stannous Fluoride

Procter & Gamble and Pfizer take opposing views on the way therapeutic stand-alone antiplaque claims should be regulated in comments submitted to FDA Feb. 20

Related Content

Topics

UsernamePublicRestriction

Register

PS095515

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel